Patent · US Active

Method for treating metabolic disorders including type 1 and type 2 diabetes mellitus

US8940691B2 · kind B2 · utility

0Cited by

1References

12Claims

0Family size

Inventors

Avadhesha Surolia · Bengaluru, IN
Sarika Gupta · Sindhar, IN
Mahendra Singh · Bound Brook, US
Tandrika Chattopadhyay · New Delhi, IN

Key dates

Filing date	Mar 18, 2013
Grant date	Jan 27, 2015
Priority date	—
Expiry date	Mar 18, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A supramolecular insulin assembly and supramolecular exendin-4 assembly, which is useful as a protein therapeutic agent for the treatment of metabolic disorders particularly diabetes. The supramolecular assemblies disclosed in the present invention consists of insoluble and aggregated oligomers the protein. The invention also provides pharmaceutical compositions comprising the supramolecular assembly.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.